\-\ Texto\\:\\ \ \(0\)\
\-\ head\\ circumference\\ 97th\\ percentile\\,\\ increased\\ from\\ 50th\\ percentile\\ only\\ 1\\ month\\ prior\\.\\ \\ some\\ neck\\ hypotonia\\,\\ unable\\ to\\ lift\\ head\\ in\\ the\\ prone\\ position\\.\\ \\ some\\ sundowning\\ of\\ the\\ eyes\\.\ \(0\)\
\-\ surgical\\ resection\\ and\\ follow\\-up\\ imaging\\.\ \(0\)\
\-\ mr\\:\\ lobulated\\,\\ intensely\\ enhancing\\,\\ fungating\\ mass\\ extending\\ superiorly\\ from\\ the\\ region\\ of\\ the\\ third\\ ventricle\\ along\\ the\\ septum\\ pellucidum\\ measuring\\ approximately\\ 5\\.3\\ x\\ 4\\.3\\ x\\ 4\\.8cm\\ \\(cc\\ x\\ ap\\ x\\ transverse\\)\\.\\ \\ there\\ is\\ associated\\ obstructive\\ hydrocephalus\\ of\\ the\\ third\\ and\\ lateral\\ ventricles\\.\\ \\ diffusion\\ weighted\\ images\\ are\\ unremarkable\\.\ \(0\)\
\-\ choroid\\ plexus\\ papilloma\ \(11\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ tumor\\ \\(papilloma\\ or\\ carcinoma\\)\ \(1\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ \\â\\€\\¢\\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ 2\\ month\\ old\\ boy\\ with\\ rapidly\\ increasing\\ head\\ circumference\\.\ \(1\)\
\-\ choroid\\ plexus\\ papilloma\\ is\\ a\\ rare\\,\\ benign\\ tumor\\ that\\ arises\\ from\\ the\\ epithelium\\ lining\\ the\\ papillae\\ of\\ the\\ choroid\\ plexus\\.\\ \\ it\\ is\\ most\\ frequently\\ encountered\\ in\\ children\\ under\\ the\\ age\\ of\\ 5\\ but\\ can\\ present\\ in\\ adulthood\\ as\\ well\\.\\ \\ although\\ choroid\\ plexus\\ papillomas\\ account\\ for\\ less\\ than\\ 1\\%\\ of\\ intracranial\\ tumors\\ in\\ children\\ of\\ all\\ ages\\,\\ they\\ represent\\ 12\\-13\\%\\ of\\ intracranial\\ tumors\\ in\\ children\\ under\\ the\\ age\\ of\\ 1\\ year\\.\ \(0\)\
\-\ choroid\\ plexus\\ papillomas\\ typically\\ arise\\ in\\ the\\ lateral\\ ventricles\\ in\\ the\\ pediatric\\ population\\,\\ with\\ the\\ fourth\\ and\\ third\\ ventricles\\ being\\ less\\ common\\.\\ \\ choroid\\ plexus\\ papillomas\\ are\\ typically\\ discovered\\ when\\ they\\ cause\\ symptoms\\ related\\ to\\ hydrocephalus\\.\ \(0\)\
\-\ typical\\ mr\\ appearance\\ of\\ a\\ choroid\\ plexus\\ papilloma\\ is\\ a\\ lobular\\ intraventricular\\ mass\\ that\\ is\\ homogeneous\\ on\\ t1\\ weighted\\ images\\.\\ \\ on\\ t2\\ weighted\\ images\\,\\ the\\ central\\ portion\\ is\\ typically\\ hypointense\\ to\\ gray\\ matter\\.\\ \\ uniform\\,\\ intense\\ enhancement\\ occurs\\ following\\ administration\\ of\\ gadolinium\\.\\ \\ occasionally\\,\\ foci\\ of\\ hemorrhage\\ or\\ calcification\\ are\\ present\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ barkovich\\,\\ a\\.j\\.\\:\\ pediatric\\ neuroimaging\\,\\ third\\ edition\\.\\ \\ lippincott\\ williams\\ \\&\\ wilkins\\,\\ philadephia\\,\\ pa\\.\\ 2000\\.\ \(0\)\
\-\ 2\\.\\ palmer\\,\\ a\\.p\\.\\,\\ harrison\\,\\ j\\.k\\.\\:\\ choroid\\ plexus\\ papilloma\\.\\ \\ emedicine\\.\\ june\\ 20\\.\\ 2006\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choroid\\:\\ 0\\.11510422331207305\ \(0\)\
\-\ plexus\\:\\ 0\\.10958567146243367\ \(0\)\
\-\ papilloma\\:\\ 0\\.06295791564395099\ \(0\)\
\-\ papillomas\\:\\ 0\\.06179260077482502\ \(0\)\
\-\ third\\:\\ 0\\.040192923098533694\ \(0\)\
\-\ ventricles\\:\\ 0\\.03536417488301839\ \(0\)\
\-\ percentile\\:\\ 0\\.034133643110923796\ \(0\)\
\-\ x\\:\\ 0\\.03306822680759504\ \(0\)\
\-\ weighted\\:\\ 0\\.03268902049392053\ \(0\)\
\-\ children\\:\\ 0\\.03247701857387014\ \(0\)\
\-\ circumference\\:\\ 0\\.032373498873678415\ \(0\)\
\-\ typically\\:\\ 0\\.02653747011295577\ \(0\)\
\-\ 4\\.8cm\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ a\\.j\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ philadephia\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ j\\.k\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ pediatric\\:\\ 0\\.024135120575801066\ \(0\)\
\-\ 97th\\:\\ 0\\.023819270508523616\ \(0\)\
\-\ sundowning\\:\\ 0\\.023819270508523616\ \(0\)\
\-\ 12\\-13\\:\\ 0\\.023819270508523616\ \(0\)\
\-\ barkovich\\:\\ 0\\.023819270508523616\ \(0\)\
\-\ papillae\\:\\ 0\\.02263022327066976\ \(0\)\
\-\ palmer\\:\\ 0\\.02263022327066976\ \(0\)\
\-\ a\\.p\\.\\:\\ 0\\.02263022327066976\ \(0\)\
\-\ under\\:\\ 0\\.021900962222768536\ \(0\)\
\-\ 50th\\:\\ 0\\.021786580829462193\ \(0\)\
\-\ hypotonia\\:\\ 0\\.021786580829462193\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0215475358795533\ \(0\)\
\-\ head\\:\\ 0\\.021322005664872988\ \(0\)\
\-\ intracranial\\:\\ 0\\.021181887019880954\ \(0\)\
\-\ harrison\\:\\ 0\\.021132200913584743\ \(0\)\
\-\ fungating\\:\\ 0\\.02014547881205626\ \(0\)\
\-\ teratoid\\/rhabdoid\\:\\ 0\\.02014547881205626\ \(0\)\
\-\ tumors\\:\\ 0\\.0188253158807654\ \(0\)\
\-\ lift\\:\\ 0\\.018820009240962252\ \(0\)\
\-\ 5\\.3\\:\\ 0\\.018820009240962252\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.01838140001872009\ \(0\)\
\-\ they\\:\\ 0\\.018058335052711472\ \(0\)\
\-\ 1\\:\\ 0\\.017888501770906513\ \(0\)\
\-\ emedicine\\:\\ 0\\.017721201471339345\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.017543416656628393\ \(0\)\
\-\ tumor\\:\\ 0\\.017526970395403033\ \(0\)\
\-\ intensely\\:\\ 0\\.01737579667469306\ \(0\)\
\-\ less\\:\\ 0\\.016973255157317787\ \(0\)\
\-\ adulthood\\:\\ 0\\.016787319561900826\ \(0\)\
\-\ lining\\:\\ 0\\.01653215423348549\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.01641244163958445\ \(0\)\
\-\ epithelium\\:\\ 0\\.01641244163958445\ \(0\)\
\-\ june\\:\\ 0\\.01641244163958445\ \(0\)\
\-\ encountered\\:\\ 0\\.016186749436839207\ \(0\)\
\-\ mr\\:\\ 0\\.015924923589128646\ \(0\)\
\-\ pellucidum\\:\\ 0\\.01587777431760804\ \(0\)\
\-\ lippincott\\:\\ 0\\.015781616479417455\ \(0\)\
\-\ wilkins\\:\\ 0\\.015343106995631638\ \(0\)\
\-\ age\\:\\ 0\\.015254606014922619\ \(0\)\
\-\ some\\:\\ 0\\.015219520550538176\ \(0\)\
\-\ pnet\\:\\ 0\\.015184552094545785\ \(0\)\
\-\ month\\:\\ 0\\.01503586240938774\ \(0\)\
\-\ prone\\:\\ 0\\.015034131876400474\ \(0\)\
\-\ arises\\:\\ 0\\.015034131876400474\ \(0\)\
\-\ edition\\:\\ 0\\.014961719522763022\ \(0\)\
\-\ williams\\:\\ 0\\.014754629882839404\ \(0\)\
\-\ uniform\\:\\ 0\\.01468872707975419\ \(0\)\
\-\ intraventricular\\:\\ 0\\.014561204757350264\ \(0\)\
\-\ 2000\\:\\ 0\\.01449946455442407\ \(0\)\
\-\ 2006\\:\\ 0\\.014438997436527483\ \(0\)\
\-\ images\\:\\ 0\\.014421676468762646\ \(0\)\
\-\ ages\\:\\ 0\\.01420887539710961\ \(0\)\
\-\ account\\:\\ 0\\.014154059757777782\ \(0\)\
\-\ lobular\\:\\ 0\\.014154059757777782\ \(0\)\
\-\ superiorly\\:\\ 0\\.01394450267865126\ \(0\)\
\-\ rapidly\\:\\ 0\\.013894372375544806\ \(0\)\
\-\ \\,\\:\\ 0\\.01349580971787063\ \(0\)\
\-\ eyes\\:\\ 0\\.013478037298505547\ \(0\)\
\-\ cc\\:\\ 0\\.013435225569997768\ \(0\)\
\-\ intense\\:\\ 0\\.013269967691548703\ \(0\)\
\-\ \\:\\:\\ 0\\.013258355612793725\ \(0\)\
\-\ occasionally\\:\\ 0\\.013190704722669174\ \(0\)\
\-\ population\\:\\ 0\\.013075687968553979\ \(0\)\
\-\ obstructive\\:\\ 0\\.012893483331876539\ \(0\)\
\-\ septum\\:\\ 0\\.012823657382628098\ \(0\)\
\-\ lobulated\\:\\ 0\\.012591583128790199\ \(0\)\
\-\ arise\\:\\ 0\\.012406307757466059\ \(0\)\
\-\ discovered\\:\\ 0\\.012347062281461603\ \(0\)\
\-\ gray\\:\\ 0\\.012260379576940946\ \(0\)\
\-\ fourth\\:\\ 0\\.01212137007871636\ \(0\)\
\-\ hypointense\\:\\ 0\\.011886640730700122\ \(0\)\
\-\ gadolinium\\:\\ 0\\.011886640730700122\ \(0\)\
\-\ homogeneous\\:\\ 0\\.011861682696483382\ \(0\)\
\-\ \\%\\:\\ 0\\.011691032453642274\ \(0\)\
\-\ unable\\:\\ 0\\.011577665611468961\ \(0\)\
\-\ present\\:\\ 0\\.011319699436549448\ \(0\)\
\-\ diffusion\\:\\ 0\\.011217260519612205\ \(0\)\
\-\ ependymoma\\:\\ 0\\.011217260519612205\ \(0\)\
\-\ from\\:\\ 0\\.01114166316557958\ \(0\)\
\-\ represent\\:\\ 0\\.011005640442637922\ \(0\)\
\-\ atypical\\:\\ 0\\.010860793652815117\ \(0\)\
\-\ frequently\\:\\ 0\\.010860793652815117\ \(0\)\
\-\ lateral\\:\\ 0\\.010830897628296483\ \(0\)\
\-\ foci\\:\\ 0\\.010756668466724472\ \(0\)\
\-\ pa\\:\\ 0\\.010480268061310428\ \(0\)\
\-\ position\\:\\ 0\\.010434085196301223\ \(0\)\
\-\ references\\:\\ 0\\.01041885112921294\ \(0\)\
\-\ administration\\:\\ 0\\.010403695791504897\ \(0\)\
\-\ related\\:\\ 0\\.010343845728070273\ \(0\)\
\-\ occurs\\:\\ 0\\.010285192746525786\ \(0\)\
\-\ increasing\\:\\ 0\\.010270710982183903\ \(0\)\
\-\ are\\:\\ 0\\.010248157236330808\ \(0\)\
\-\ transverse\\:\\ 0\\.010048230774633423\ \(0\)\
\-\ typical\\:\\ 0\\.010048230774633423\ \(0\)\
\-\ measuring\\:\\ 0\\.010021571033574034\ \(0\)\
\-\ is\\:\\ 0\\.009893679385068486\ \(0\)\
\-\ matter\\:\\ 0\\.009866510177128439\ \(0\)\
\-\ rare\\:\\ 0\\.00973123225417389\ \(0\)\
\-\ ventricle\\:\\ 0\\.009391173951842897\ \(0\)\
\-\ ap\\:\\ 0\\.009164689060535008\ \(0\)\
\-\ calcification\\:\\ 0\\.009096145508671933\ \(0\)\
\-\ portion\\:\\ 0\\.009076852338296441\ \(0\)\
\-\ 20\\:\\ 0\\.00901030861043113\ \(0\)\
\-\ \\&\\:\\ 0\\.008801724023875166\ \(0\)\
\-\ being\\:\\ 0\\.008732516060998705\ \(0\)\
\-\ that\\:\\ 0\\.008656778466620664\ \(0\)\
\-\ in\\:\\ 0\\.008650383023406993\ \(0\)\
\-\ benign\\:\\ 0\\.00864824154555191\ \(0\)\
\-\ boy\\:\\ 0\\.008518245688932467\ \(0\)\
\-\ cause\\:\\ 0\\.008478776030944182\ \(0\)\
\-\ although\\:\\ 0\\.008463135720165993\ \(0\)\
\-\ extending\\:\\ 0\\.008424396037653364\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.008340928399343214\ \(0\)\
\-\ unremarkable\\:\\ 0\\.008296382459478184\ \(0\)\
\-\ along\\:\\ 0\\.008281682923338756\ \(0\)\
\-\ central\\:\\ 0\\.008245253245923633\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.008152601147922997\ \(0\)\
\-\ 2\\.\\:\\ 0\\.00796904440410633\ \(0\)\
\-\ t1\\:\\ 0\\.007942802159015378\ \(0\)\
\-\ enhancing\\:\\ 0\\.007859101269456771\ \(0\)\
\-\ 1\\.\\:\\ 0\\.007827534212016424\ \(0\)\
\-\ resection\\:\\ 0\\.007815001922346682\ \(0\)\
\-\ approximately\\:\\ 0\\.00775313145617473\ \(0\)\
\-\ only\\:\\ 0\\.0075349315498091955\ \(0\)\
\-\ neck\\:\\ 0\\.007358484272781474\ \(0\)\
\-\ 5\\:\\ 0\\.007331848746170567\ \(0\)\
\-\ when\\:\\ 0\\.00717692445048682\ \(0\)\
\-\ appearance\\:\\ 0\\.007166881456699828\ \(0\)\
\-\ following\\:\\ 0\\.0071122514865136315\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007102427184797262\ \(0\)\
\-\ t2\\:\\ 0\\.007092635685484903\ \(0\)\
\-\ all\\:\\ 0\\.007087752168420208\ \(0\)\
\-\ region\\:\\ 0\\.007078009464044905\ \(0\)\
\-\ mass\\:\\ 0\\.006970445788548766\ \(0\)\
\-\ enhancement\\:\\ 0\\.006716975853733243\ \(0\)\
\-\ than\\:\\ 0\\.006566125674247137\ \(0\)\
\-\ common\\:\\ 0\\.006557968363508496\ \(0\)\
\-\ prior\\:\\ 0\\.006434348305578779\ \(0\)\
\-\ symptoms\\:\\ 0\\.0062453298442760674\ \(0\)\
\-\ increased\\:\\ 0\\.006130453905570838\ \(0\)\
\-\ the\\:\\ 0\\.006081346834470343\ \(0\)\
\-\ associated\\:\\ 0\\.005913379946943407\ \(0\)\
\-\ or\\:\\ 0\\.005874033718262214\ \(0\)\
\-\ imaging\\:\\ 0\\.005871184235940184\ \(0\)\
\-\ most\\:\\ 0\\.005785440298322803\ \(0\)\
\-\ can\\:\\ 0\\.005683936517504603\ \(0\)\
\-\ well\\:\\ 0\\.005668859099614812\ \(0\)\
\-\ it\\:\\ 0\\.005632986464906207\ \(0\)\
\-\ 2\\:\\ 0\\.0053962008695323934\ \(0\)\
\-\ but\\:\\ 0\\.005344584460508908\ \(0\)\
\-\ surgical\\:\\ 0\\.005267512522731535\ \(0\)\
\-\ on\\:\\ 0\\.004245695087187262\ \(0\)\
\-\ \\(\\:\\ 0\\.004236725667119416\ \(0\)\
\-\ \\)\\:\\ 0\\.004184971801251056\ \(0\)\
\-\ of\\:\\ 0\\.004099840497289915\ \(0\)\
\-\ as\\:\\ 0\\.003790549870657266\ \(0\)\
\-\ to\\:\\ 0\\.003757197434982284\ \(0\)\
\-\ there\\:\\ 0\\.0037293711333284125\ \(0\)\
\-\ a\\:\\ 0\\.0034891478165859353\ \(0\)\
\-\ year\\:\\ 0\\.002803827769128782\ \(0\)\
\-\ \\.\\:\\ 0\\.0027067094971583673\ \(0\)\
\-\ old\\:\\ 0\\.002565790606634178\ \(0\)\
\-\ for\\:\\ 0\\.002138147063468373\ \(0\)\
\-\ and\\:\\ 0\\.0015836569419256756\ \(0\)\
\-\ with\\:\\ 0\\.0006862415019934882\ \(0\)\
